Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Nuwellis Inc's Business Segments
Nuwellis Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Fluid Overload
Total Revenue
$ 2
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Fluid Overload100%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Fluid Overload | $ 2 | 100% |
Description of Nuwellis Inc
Nuwellis Inc. is a medical technology company that specializes in the development and commercialization of innovative medical devices and therapies for patients suffering from chronic conditions. The company's core focus is on the design and manufacture of advanced solutions that enhance clinical outcomes, improve patient quality of life, and reduce healthcare costs.
Nuwellis is headquartered in Eden Prairie, Minnesota, and was originally founded in 1991. The company was previously known as Sunshine Heart Inc. but underwent a name change in 2019. It operates globally, with a presence in various countries including the United States, Europe, Australia, and New Zealand.
The primary area of expertise for Nuwellis lies in their patented fluid overload management technology. The company's flagship product, known as the Aquadex FlexFlow® system, is a highly innovative medical device for removing excess fluid from patients suffering from congestive heart failure (CHF), fluid overload, and other related conditions. The Aquadex FlexFlow system offers a minimally invasive, precise, and portable solution for clinicians to effectively manage fluid balance in patients, ultimately reducing the chances of hospitalization and improving overall patient outcomes.
The Aquadex FlexFlow system utilizes a patented process called ultrafiltration, which involves the gentle removal of excess fluid from patients' blood through a semi-permeable membrane. This process is controlled by an intelligent console that allows healthcare professionals to individualize treatment parameters for each patient, ensuring safety and optimizing therapy effectiveness. The console provides real-time data on fluid removal rates, pressure, and other relevant parameters, giving clinicians the ability to closely monitor and adjust therapy as needed.
Apart from fluid overload management, Nuwellis also aims to expand its product portfolio and therapeutic offerings. The company is actively engaged in research and development efforts to develop additional products utilizing its unique fluid removal technology. These efforts include exploring applications in different areas such as acute cardiorenal syndrome, sepsis, and liver disease. Nuwellis also continuously seeks collaborations and partnerships with healthcare institutions, universities, and other industry players to drive innovation and develop new solutions that address unmet medical needs.
In addition to its product development efforts, Nuwellis places significant emphasis on providing education and training programs to healthcare professionals. The company offers comprehensive training and certification programs to ensure that clinicians are equipped with the necessary skills and knowledge to maximize the potential of their products.
Overall, Nuwellis Inc. is a pioneering company in the field of fluid overload management technology. It is committed to improving the lives of patients suffering from chronic conditions through innovative medical devices and therapies. With a strong focus on research, development, and collaboration, the company is poised to continue delivering cutting-edge solutions that have a positive impact on patient outcomes and healthcare practices worldwide.
Nuwellis is headquartered in Eden Prairie, Minnesota, and was originally founded in 1991. The company was previously known as Sunshine Heart Inc. but underwent a name change in 2019. It operates globally, with a presence in various countries including the United States, Europe, Australia, and New Zealand.
The primary area of expertise for Nuwellis lies in their patented fluid overload management technology. The company's flagship product, known as the Aquadex FlexFlow® system, is a highly innovative medical device for removing excess fluid from patients suffering from congestive heart failure (CHF), fluid overload, and other related conditions. The Aquadex FlexFlow system offers a minimally invasive, precise, and portable solution for clinicians to effectively manage fluid balance in patients, ultimately reducing the chances of hospitalization and improving overall patient outcomes.
The Aquadex FlexFlow system utilizes a patented process called ultrafiltration, which involves the gentle removal of excess fluid from patients' blood through a semi-permeable membrane. This process is controlled by an intelligent console that allows healthcare professionals to individualize treatment parameters for each patient, ensuring safety and optimizing therapy effectiveness. The console provides real-time data on fluid removal rates, pressure, and other relevant parameters, giving clinicians the ability to closely monitor and adjust therapy as needed.
Apart from fluid overload management, Nuwellis also aims to expand its product portfolio and therapeutic offerings. The company is actively engaged in research and development efforts to develop additional products utilizing its unique fluid removal technology. These efforts include exploring applications in different areas such as acute cardiorenal syndrome, sepsis, and liver disease. Nuwellis also continuously seeks collaborations and partnerships with healthcare institutions, universities, and other industry players to drive innovation and develop new solutions that address unmet medical needs.
In addition to its product development efforts, Nuwellis places significant emphasis on providing education and training programs to healthcare professionals. The company offers comprehensive training and certification programs to ensure that clinicians are equipped with the necessary skills and knowledge to maximize the potential of their products.
Overall, Nuwellis Inc. is a pioneering company in the field of fluid overload management technology. It is committed to improving the lives of patients suffering from chronic conditions through innovative medical devices and therapies. With a strong focus on research, development, and collaboration, the company is poised to continue delivering cutting-edge solutions that have a positive impact on patient outcomes and healthcare practices worldwide.
Nuwellis Inc. is a healthcare-focused company that specializes in the development and commercialization of innovative solutions aimed at managing fluid overload and kidney-related conditions. The company’s primary offerings are centered around their proprietary technology and related products that enhance patient management and treatment outcomes. Below is an extensive description of the segments, products, and services provided by Nuwellis Inc.
Segments
1. Medical Devices:
- Fluid Management: Nuwellis Inc. primarily focuses on devices that assist in the management of fluid overload conditions, which is often critical in patients with heart failure and kidney disorders.
- Kidney Care: The company has developed technologies to improve care for patients suffering from acute or chronic kidney conditions, offering targeted solutions that help manage waste removal and fluid regulation.
2. Healthcare Services:
- Patient Monitoring: Nuwellis may offer integrated services that include monitoring patients’ fluid status and ensuring optimal treatment adherence.
- Education and Training: They provide comprehensive training for healthcare professionals, focusing on the use of their devices, understanding kidney function, and managing fluid overload.
3. Clinical Research:
- Nuwellis is likely involved in research collaborations aimed at advancing the understanding of fluid overload and kidney health, contributing to the development of new products and improving existing offerings.
Products
1. The Aquadex FlexFlow System:
- This is a key product from Nuwellis, designed for ultrafiltration therapy in patients with fluid overload. It is specifically tailored for use in patients with conditions such as heart failure and has shown efficacy in effectively removing excess fluid without the need for more invasive interventions.
- The system features a lightweight, portable design that allows for easy use in hospital settings and potentially at home, improving patient comfort and mobility.
2. Consumables and Accessories:
- Nuwellis offers a range of consumable items necessary for the operation of their Aquadex FlexFlow System. These include blood filters, tubing sets, and other specialized components that ensure optimal performance of the device while maintaining patient safety.
3. Disposables:
- Disposable components are critical for ensuring that the systems are hygienic and safe for patient use. Nuwellis focuses on producing high-quality disposable items that comply with medical standards.
4. Software Solutions:
- Nuwellis may provide software integration capabilities that allow healthcare providers to monitor patient data, track fluid removal efficiency, and adjust treatment protocols in real time, improving overall patient management.
Services
1. Clinical Support:
- Nuwellis likely offers comprehensive support services for clinicians regarding the deployment and operation of their devices, ensuring proper usage and maximizing therapeutic benefits for patients.
2. Regulatory Guidance:
- Given the complex regulatory landscape for medical devices, Nuwellis may provide services that assist healthcare organizations in navigating compliance requirements for utilizing their products.
3. Research Partnerships:
- Nuwellis may actively seek partnerships with academic institutions and healthcare organizations to conduct clinical trials and research studies aimed at validating the effectiveness of their technologies, contributing to broader knowledge in the field.
4. Customer Support:
- Nuwellis emphasizes customer service and technical support to ensure that healthcare providers have immediate access to assistance for any device-related inquiries or issues.
5. Training Programs:
- Ongoing education and training programs aimed at healthcare professionals ensure that users are well-informed about new features, best practices, and the latest in fluid management techniques.
In summary, Nuwellis Inc. offers a wide range of products and services that cater to the pressing healthcare needs associated with fluid overload and kidney management. Their focus on innovative technology, clinical support, and patient-centered solutions positions them as an important player in the healthcare sector dedicated to improving patient outcomes.
Segments
1. Medical Devices:
- Fluid Management: Nuwellis Inc. primarily focuses on devices that assist in the management of fluid overload conditions, which is often critical in patients with heart failure and kidney disorders.
- Kidney Care: The company has developed technologies to improve care for patients suffering from acute or chronic kidney conditions, offering targeted solutions that help manage waste removal and fluid regulation.
2. Healthcare Services:
- Patient Monitoring: Nuwellis may offer integrated services that include monitoring patients’ fluid status and ensuring optimal treatment adherence.
- Education and Training: They provide comprehensive training for healthcare professionals, focusing on the use of their devices, understanding kidney function, and managing fluid overload.
3. Clinical Research:
- Nuwellis is likely involved in research collaborations aimed at advancing the understanding of fluid overload and kidney health, contributing to the development of new products and improving existing offerings.
Products
1. The Aquadex FlexFlow System:
- This is a key product from Nuwellis, designed for ultrafiltration therapy in patients with fluid overload. It is specifically tailored for use in patients with conditions such as heart failure and has shown efficacy in effectively removing excess fluid without the need for more invasive interventions.
- The system features a lightweight, portable design that allows for easy use in hospital settings and potentially at home, improving patient comfort and mobility.
2. Consumables and Accessories:
- Nuwellis offers a range of consumable items necessary for the operation of their Aquadex FlexFlow System. These include blood filters, tubing sets, and other specialized components that ensure optimal performance of the device while maintaining patient safety.
3. Disposables:
- Disposable components are critical for ensuring that the systems are hygienic and safe for patient use. Nuwellis focuses on producing high-quality disposable items that comply with medical standards.
4. Software Solutions:
- Nuwellis may provide software integration capabilities that allow healthcare providers to monitor patient data, track fluid removal efficiency, and adjust treatment protocols in real time, improving overall patient management.
Services
1. Clinical Support:
- Nuwellis likely offers comprehensive support services for clinicians regarding the deployment and operation of their devices, ensuring proper usage and maximizing therapeutic benefits for patients.
2. Regulatory Guidance:
- Given the complex regulatory landscape for medical devices, Nuwellis may provide services that assist healthcare organizations in navigating compliance requirements for utilizing their products.
3. Research Partnerships:
- Nuwellis may actively seek partnerships with academic institutions and healthcare organizations to conduct clinical trials and research studies aimed at validating the effectiveness of their technologies, contributing to broader knowledge in the field.
4. Customer Support:
- Nuwellis emphasizes customer service and technical support to ensure that healthcare providers have immediate access to assistance for any device-related inquiries or issues.
5. Training Programs:
- Ongoing education and training programs aimed at healthcare professionals ensure that users are well-informed about new features, best practices, and the latest in fluid management techniques.
In summary, Nuwellis Inc. offers a wide range of products and services that cater to the pressing healthcare needs associated with fluid overload and kidney management. Their focus on innovative technology, clinical support, and patient-centered solutions positions them as an important player in the healthcare sector dedicated to improving patient outcomes.